Dimou, M.; Vacca, A.; Sánchez-Ramón, S.; Karakulska-Prystupiuk, E.; Lionikaite, V.; Siffel, C.; Anderson-Smits, C.; Kamieniak, M.
Real-World Effectiveness, Safety, and Tolerability of Facilitated Subcutaneous Immunoglobulin 10% in Secondary Immunodeficiency Disease: A Systematic Literature Review. J. Clin. Med. 2025, 14, 1203.
https://doi.org/10.3390/jcm14041203
AMA Style
Dimou M, Vacca A, Sánchez-Ramón S, Karakulska-Prystupiuk E, Lionikaite V, Siffel C, Anderson-Smits C, Kamieniak M.
Real-World Effectiveness, Safety, and Tolerability of Facilitated Subcutaneous Immunoglobulin 10% in Secondary Immunodeficiency Disease: A Systematic Literature Review. Journal of Clinical Medicine. 2025; 14(4):1203.
https://doi.org/10.3390/jcm14041203
Chicago/Turabian Style
Dimou, Maria, Angelo Vacca, Silvia Sánchez-Ramón, Ewa Karakulska-Prystupiuk, Vikte Lionikaite, Csaba Siffel, Colin Anderson-Smits, and Marta Kamieniak.
2025. "Real-World Effectiveness, Safety, and Tolerability of Facilitated Subcutaneous Immunoglobulin 10% in Secondary Immunodeficiency Disease: A Systematic Literature Review" Journal of Clinical Medicine 14, no. 4: 1203.
https://doi.org/10.3390/jcm14041203
APA Style
Dimou, M., Vacca, A., Sánchez-Ramón, S., Karakulska-Prystupiuk, E., Lionikaite, V., Siffel, C., Anderson-Smits, C., & Kamieniak, M.
(2025). Real-World Effectiveness, Safety, and Tolerability of Facilitated Subcutaneous Immunoglobulin 10% in Secondary Immunodeficiency Disease: A Systematic Literature Review. Journal of Clinical Medicine, 14(4), 1203.
https://doi.org/10.3390/jcm14041203
